Taking a Look at the Patent Provisions from the India-UK CETA: Does it Set a Course for Future Trade Negotiations for India?

Two months after showing up in the news, the text of the India-UK Comprehensive Economic and Trade Agreement (CETA) was signed and published on July 24. The Agreement is being touted as a “Historic” and “Landmark” trade deal, which is supposed to give unprecedented market access to Indian goods in the UK. This comes at an interesting time, in the midst of ongoing India-US trade agreement talks, which are being conducted under the looming threat of August 1 reciprocal tariff […]

Taking a Look at the Patent Provisions from the India-UK CETA: Does it Set a Course for Future Trade Negotiations for India? Read More »

E.R. Squibb v. Zydus: Why the Delhi HC’s Take on Biosimilars May Set a Dangerous Precedent

In the past two months, Zydus Lifesciences has faced two legal setbacks in litigations for its biosimilar medicines. In April, the U.S. District Court of Delaware rejected Zydus’s challenge against the validity of Astellas’s patent on Myrbetriq, dealing a blow to Zydus’s plan to launch a generic version of the drug in U.S. On 18th July, the Delhi HC dealt another blow– it restrained Zydus from manufacturing, selling, offering for sale, importing, exporting, advertising or dealing in any bio-similar of Nivolumab.  The

E.R. Squibb v. Zydus: Why the Delhi HC’s Take on Biosimilars May Set a Dangerous Precedent Read More »

Reframing Procedural Fairness in Patent Amendments: A Comparative Look at Dong Yang and Srinivas Jegannathan’s Reversals

Explaining two recent judgements on amendments- Dong Yang PC Inc. v Controller of Patents and Designs (Delhi HC) and Srinivas Jegannathan v Controller of Patents (Madras HC), S. Sri Ganesh Prasad, argues how they point towards the need for the patent office to fulfil its quasi-judicial role in patent prosecution with clarity and evidence. Ganesh is a third-year B.A. LL.B. (Hons.) student at the West Bengal National University of Juridical Sciences (WBNUJS), Kolkata. He is interested in a wide range

Reframing Procedural Fairness in Patent Amendments: A Comparative Look at Dong Yang and Srinivas Jegannathan’s Reversals Read More »

Prima Facie, Not Per Se: Rebuilding SEP Interim Jurisprudence after Nokia v Oppo

On the recent Delhi High Court decision in Dolby v. Lava, directing the India-based implementer to pay INR 20.81 Crores as pro-tem security, Shailraj Jhalnia argues for a more balanced approach on how the Courts should calculate such deposits, keeping in mind the interests of both the SEP holders and implementers. Shailraj is a third year law student pursuing B.A. LL.B. from National Law School of India University, Bangalore, with a keen interest in IP Law, Arbitration and Criminal Law.

Prima Facie, Not Per Se: Rebuilding SEP Interim Jurisprudence after Nokia v Oppo Read More »

https://i.imgflip.com/a0vx9q.jpg

Keeping Up with The (GM) Crops: Comments and Caveats on the GEAC’s Punjab GM Crop Trials

[A big thanks to Daanish Naithani for his inputs in the post.] If you were following the Genetically Modified (GM) crops dilemma last year but failed to keep up over the past year, don’t worry. Fortunately (and unfortunately, when seen in the broader scope), you haven’t really missed much. In July last year, as covered here on the blog, the Supreme Court (SC) delivered a split verdict on the commercial sale of Genetically Modified Mustard (GM Mustard) in India in

Keeping Up with The (GM) Crops: Comments and Caveats on the GEAC’s Punjab GM Crop Trials Read More »

[Sponsored] Crack the Patent Agent Exam – Join India’s Most Trusted Training Program

Edu Literati is now inviting applications for its Patent Agent Exam 2026 Training Programme. The programme fee is ₹25,000 and SpicyIP readers can avail a 20% discount by using the coupon code SPICYIP at checkout. This special offer is valid for a limited number of seats, so early registration is recommended. To learn more about the programme, check out the details below: [Sponsored] Crack the Patent Agent Exam – Join India’s Most Trusted Training Program The Indian Patent Office has

[Sponsored] Crack the Patent Agent Exam – Join India’s Most Trusted Training Program Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (July 14-July 20)

DHC’s recent decisions on the Pisco GI Tag, comments on the draft CRI guidelines, DHC’s decision putting a stay on a judgement directing Amazon to pay ₹339 crore in damages and costs- This and much more in our weekly roundup of our blog posts, case summaries, and top IP developments in the country and the world. Anything we are missing out on? Drop a comment below to let us know. Highlights of the Week GI Protection in High Spirits in

SpicyIP Weekly Review (July 14-July 20) Read More »

The WHO Pandemic Agreement: A Contested Step Beyond Doha

Taking a look at the recent Pandemic Treaty, Dr. Siddarth Jain explains how its provisions differ—both positively and negatively—from the 2001 Doha Declaration. Siddarth holds a PhD from the School of Social Sciences, Centre for Studies in Science Policy, Jawaharlal Nehru University, New Delhi, and is interested in IP, technology transfer, and innovation studies. He was also a participant in the recently concluded SpicyIP Summer School 2025, where this was one of the many topics of discussion that had come

The WHO Pandemic Agreement: A Contested Step Beyond Doha Read More »

Procedure, Pleadings, and Platforms: DHC’s Stay in Amazon v. Lifestyle

Recently, a DB of the DHC passed a stay on the Amazon v. Lifestyle decision granting  ₹339 crore in damages and costs on Amazon Technologies, Inc for trademark infringement. Khushi Jain and Vishno Sudheendra explain the DB judgement, discussing how it recalibrates the contours of licensor and e-commerce liability in trademark infringement disputes. Khushi is a fourth-year B.A., LL.B (Hons) student at the National Law University Delhi with a keen interest in the intersection of law and policy. Vishno is

Procedure, Pleadings, and Platforms: DHC’s Stay in Amazon v. Lifestyle Read More »

Comments on Revised Draft CRI Guidelines 2025- Version 2.0, really? 

On 26 June, the CGPDTM issued a public notice inviting comments on the “Revised Draft CRI Guidelines 2025, Version 2.0.” Earlier, in May 2025, we had submitted our comments on the previous edition of the CRI guidelines. (here) This time around, the CGPDTM had organised in-person stakeholder meetings to discuss the comments received for the first version of these guidelines. Bharathwaj Ramakrishnan, our prolific blogger, had attended one of these meeting in Chennai on our behalf.  To CGPDTM’s credit, organising stakeholder meetings goes a long way in increasing transparency

Comments on Revised Draft CRI Guidelines 2025- Version 2.0, really?  Read More »

Scroll to Top